ABPI Code Mentorship Training
1:1 and team coaching to sharpen approval judgement, reduce rework, and strengthen compliant decision-making—led by an ABPI Final Medical Signatory.
-
- Signatory-ready thinking for originators, reviewers, AQPs and final signatories
-
- Real case learning using completed PMCPA cases (not theory-only)
- - Immediate impact on job bags, claims, meetings, and digital content
ABPI Final Medical Signatory • GMC Registered Pharmaceutical Physician • MBA (LBS) • FFPM
- More consistent decisions across Marketing, Medical, and Compliance
- Stronger claims with cleaner evidence logic and balance
- More consistent decisions across Marketing, Medical, and Compliance
- Reduced PMCPA risk in high-pressure situations (meetings, congresses, digital)
Who is this for?
Medical, Scientific and Marketing reviewers
Originators writing job bags and core materials
AQPs and compliance colleagues
Final signatories who want faster, safer approvals
Field/brand teams planning meetings,
congress activity and digital
How it works
A structured 12-week mentorship that improves approval judgement - fast.
Each week combines bite-sized learning with real-world application—so you strengthen compliant decision-making, reduce rework, and feel confident defending claims across job bags, meetings, and digital content.
Weekly modules + podcasts + case-based quizzes
Each week focuses on one high-risk ABPI area (claims, meetings, digital, public, etc.) with real PMCPA case patterns and “what good looks like” examples—so the learning is immediately usable. Every week includes short learning modules and an accompanying podcast, plus PMCPA-inspired case studies with quizzes to lock in the “why” behind decisions—without drowning in clauses.
Live coaching, plus workshop + 1:1 viva feedback
A weekly session turns the module into action: we stress-test real scenarios, fix common pitfalls, and build your team’s confidence to make faster, defensible decisions on job bags and campaigns. Weekly sessions apply the learning to real scenarios and materials. The programme finishes with a hands-on workshop, and each participant receives individual 1:1 viva-style feedback to sharpen judgement and close gaps fast.
FAQ
Frequently Asked Questions
This mentorship is designed for pharma professionals who work with ABPI decisions day-to-day: originators, medical/scientific/marketing reviewers, AQPs, compliance colleagues, and final signatories. It’s especially useful for teams who want faster approvals with fewer iterations and stronger, more defensible claims.
You’ll build signatory-ready judgement across the areas that trigger most rework and risk—claims, meetings/congress activity, digital/social, patient-facing/public content, and transfers of value. The outcome is clearer decision-making, cleaner evidence logic, and fewer “back-and-forth” cycles.
Each week you’ll get a short learning module plus a supporting podcast, followed by a live session to apply it to practical scenarios and real-world patterns from completed PMCPA cases. Most teams find the learning is immediately usable in current job bags.
No. We focus on practical judgement and how to think like a signatory—what good looks like, what creates risk, and how to make decisions that stand up to scrutiny. Clauses are used when helpful, but the core is application and decision-making.
Yes—sessions are grounded in real patterns from completed PMCPA cases (in an educational way). The point is to show how issues arise in practice, how they’re interpreted, and what to do differently next time.
Yes. The programme ends with a hands-on workshop that pulls everything together, stress-tests judgement, and helps teams standardise what “acceptable” looks like across Marketing, Medical, and Compliance.
Each participant receives an individual 1:1 feedback session in a viva-style format—focused on strengthening reasoning, identifying blind spots, and improving how you justify decisions. This is often where confidence increases fastest.
Absolutely. Team cohorts are one of the best use-cases because it creates a shared “decision language” across functions and reduces internal inconsistency. We can tailor examples and exercises to your therapy area and material types.
Yes. The programme can be aligned to your internal workflows so learning translates directly into better job bags, smoother reviews, and fewer late-stage escalations.
Yes—participants get practical tools and frameworks (e.g., decision checklists, claim-strengthening logic, and risk spotting prompts), plus case-based learning they can refer back to.
Typically online to make it easy for busy teams, but the end workshop can also be delivered in-person if needed (depending on location and scheduling).
Click Book a Call and share your team size and the types of materials you want to improve (e.g., job bags, meetings, congress, digital). We’ll confirm fit, tailor the focus areas, and agree dates.
Insights & PMCPA Cases

AI-Enabled MLR in Pharma: Governance First Guide
AI tools can enhance Medical affairs MLR workflows but pose governance challenges. It’s crucial to implement strict controls, maintain compliance with the ABPI Code, and ensure documented human oversight.
AstraZeneca: promotional meeting misclassified and LinkedIn ‘likes/reposts’ led to pre-authorisation promotion and public advertising concerns (AUTH/3729/1/23)
Six complaints against AstraZeneca. Breaches found for a UK meeting treated as non-promotional (certification/PI and ‘cure’ claims) and for LinkedIn engagement promoting an unlicensed medicine and a POM to the public.

Blurred boundaries: Lessons from the Eli Lilly Facebook Breast Cancer Ad (CASE/3869/12/23)
TL;DR: Even a globally reputable company using trusted partners can stumble into serious compliance breaches online. All pharma professionals should be proactive, transparent, and vigilant—especially with third-party digital campaigns. The future of ethical pharmaceutical advertising depends on it. For many in pharma, the digital landscape can feel like quicksand—seemingly solid
